WebSep 27, 2024 · Intra-Cellular Therapies, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several Underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of 9,677,419 shares of common stock, par value $0.0001 per share (the … WebAug 26, 2014 · Industry executive with successful track record on developing and executing strategies to drive innovation, shape corporate strategy, and create new business opportunities in small and large ...
What Kind Of Shareholders Hold The Majority In Intra-Cellular …
WebJun 15, 2024 · Has Intra-Cellular Therapies, Inc. Been A Good Investment? Boasting a total shareholder return of 111% over three years, Intra-Cellular Therapies, Inc. has … WebIntra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. the very revd roger bush
What Kind Of Investors Own Most Of Intra-Cellular Therapies, Inc ...
WebRegional Business Manager, New England. INTRA-CELLULAR THERAPIES INC. Remote in United States +5 locations. Estimated $90.2K - $114K a year. WebApr 10, 2024 · ITCI Stock Overview. Intra-Cellular Therapies, Inc., a biopharmaceutical company, focuses on the discovery, clinical development, and commercialization of small molecule drugs that address medical needs primarily in neuropsychiatric and neurological disorders by targeting intracellular signaling mechanisms in the central nervous system … WebDec 5, 2024 · We did this open-label, cluster-randomised trial (DiRECT) at 49 primary care practices in Scotland and the Tyneside region of England. Practices were randomly assigned (1:1), via a computer-generated list, to provide either a weight management programme (intervention) or best-practice care by guidelines (control), with stratification … the very revd dr robert willis